SCHEMBL7608609

SCHEMBL7608609

OC1CCCC(n2c(NC3CC3)nc3cc(Cl)c(Cl)cc32)C1O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNT1 O60563 2/20 0.41
CDK9 P50750 2/20 0.41
HDAC6 Q9UBN7 1/20 0.40
PRPS1 P60891 3/20 0.35
KMT5B Q4FZB7 1/20 0.32
KMT5C Q86Y97 1/20 0.32
IRAK4 Q9NWZ3 1/20 0.32
AHCY P23526 1/20 0.32
MAPK14 Q16539 1/20 0.31
SOS1 Q07889 1/20 0.31
MTHFD2 P13995 1/20 0.31
KDM4E B2RXH2 1/20 0.30
MEN1 O00255 1/20 0.30
NPC1 O15118 1/20 0.30
ALDH1A1 P00352 1/20 0.30
GLA P06280 1/20 0.30
POLB P06746 1/20 0.30
GAA P10253 1/20 0.30
MAPT P10636 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7608610 1.00 CCNT1 (0.41) CCNT1CDK9HDAC6PRPS1KMT5B
SCHEMBL7608607 0.90 CCNT1 (0.46) CCNT1CDK9HDAC6PRPS1KMT5B
SCHEMBL7608598 0.90 CCNT1 (0.46) CCNT1CDK9HDAC6PRPS1KMT5B
SCHEMBL7608602 0.90 CCNT1 (0.46) CCNT1CDK9HDAC6PRPS1KMT5B
SCHEMBL8794070 0.81 CCNT1 (0.40) CCNT1CDK9HDAC6IRAK4MAPK14
SCHEMBL8794075 0.81 CCNT1 (0.40) CCNT1CDK9HDAC6IRAK4MAPK14
SCHEMBL9062639 0.80 HDAC6 (0.43) CCNT1CDK9HDAC6IRAK4AHCY
SCHEMBL9062645 0.80 HDAC6 (0.43) CCNT1CDK9HDAC6IRAK4AHCY
SCHEMBL7611059 0.80 CCNT1 (0.45) CCNT1CDK9HDAC6PRPS1AHCY
SCHEMBL7643447 0.80 CCNT1 (0.45) CCNT1CDK9HDAC6PRPS1AHCY

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6455507-B1 E.G., 2-BROMO-5,6-DICHLORO-1-BETA-D-RIBOPYRANOSYL-1H-BENZIMIDAZOLE; VIRICIDES, ESPECIALLY INFECTIONS OF HERPES AND CYTOMEGALO VIRUSES SMITHKLINE BEECHAM CORPORATION 2002-09-24 US disclosed
US-20020094963-A1 BENZIMIDAZOLE DERIVATIVES GLAXO WELLCOME INC. 2002-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020094963-A1 BENZIMIDAZOLE DERIVATIVES ZC3HAV1, BRPF3, BRD3 CCNT1 483/4885CDK9 138/4885HDAC6 44/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.